ARCUS VENTURES
Arcus Ventures is a private equity firm that invests in oncology-focused companies with advanced biopharmaceuticals. It also finances new drug delivery platforms in development, device companies with products that have pre-marketing approval, and service companies with positive revenue. Arcus Ventures was founded in 2007 by Steven L. Soignet, and James B. Dougherty. It is headquartered in New York, United States.
ARCUS VENTURES
Social Links:
Industry:
Biotechnology Finance Financial Services
Founded:
2007-01-01
Status:
Active
Contact:
212-785-2236
Email Addresses:
[email protected]
Technology used in webpage:
SPF Google Analytics Microsoft Exchange Online Amazon Office 365 Mail Microsoft Azure DNS ASP.NET JQuery CDN IIS Sectigo SSL
Current Employees Featured
Steven L. Soignet
Steven L. Soignet Founding/ General Partner @ Arcus Ventures Founding/ General Partner 2007-10-01
James B. Dougherty
James B. Dougherty Co-Founder & General Partner @ Arcus Ventures Co-Founder & General Partner 2007-01-01
Founder
James B. Dougherty
Steven L. Soignet
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2019-08-06 | Cleave Therapeutics | Arcus Ventures investment in Series C - Cleave Therapeutics | 12 M USD |
2017-07-24 | Exosome Diagnostics | Arcus Ventures investment in Series C - Exosome Diagnostics | 30 M USD |
2016-08-17 | Cleave Therapeutics | Arcus Ventures investment in Series B - Cleave Therapeutics | 25.95 M USD |
2016-01-07 | Exosome Diagnostics | Arcus Ventures investment in Series B - Exosome Diagnostics | 16 M USD |
2015-09-02 | Exosome Diagnostics | Arcus Ventures investment in Series B - Exosome Diagnostics | 17.6 M USD |
2015-06-11 | XTuit Pharmaceuticals | Arcus Ventures investment in Series A - XTuit Pharmaceuticals | 22 M USD |
2014-09-22 | TRACON Pharmaceuticals | Arcus Ventures investment in Series B - TRACON Pharmaceuticals | 27 M USD |
2014-07-30 | Epic Sciences | Arcus Ventures investment in Series C - Epic Sciences | 30 M USD |
2014-03-11 | Exosome Diagnostics | Arcus Ventures investment in Series B - Exosome Diagnostics | 27 M USD |
2013-10-02 | MI Bioresearch | Arcus Ventures investment in Series B - MI Bioresearch | 3.5 M USD |